IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 214 filers reported holding IMMUNOGEN INC in Q4 2020. The put-call ratio across all filers is 0.99 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $865 | +437.3% | 54,518 | +541.9% | 0.00% | – |
Q2 2023 | $161 | +5.2% | 8,493 | -78.6% | 0.00% | – |
Q1 2023 | $153 | +206.0% | 39,635 | +294.8% | 0.00% | – |
Q4 2022 | $50 | -99.9% | 10,039 | 0.0% | 0.00% | – |
Q3 2022 | $48,000 | +6.7% | 10,039 | 0.0% | 0.00% | – |
Q2 2022 | $45,000 | -11.8% | 10,039 | 0.0% | 0.00% | – |
Q1 2022 | $51,000 | -31.1% | 10,039 | 0.0% | 0.00% | – |
Q4 2021 | $74,000 | +29.8% | 10,039 | 0.0% | 0.00% | – |
Q3 2021 | $57,000 | -13.6% | 10,039 | 0.0% | 0.00% | – |
Q2 2021 | $66,000 | -38.9% | 10,039 | -25.1% | 0.00% | – |
Q1 2021 | $108,000 | +74.2% | 13,402 | +39.6% | 0.00% | – |
Q4 2020 | $62,000 | +77.1% | 9,603 | 0.0% | 0.00% | – |
Q3 2020 | $35,000 | -20.5% | 9,603 | 0.0% | 0.00% | – |
Q2 2020 | $44,000 | +51.7% | 9,603 | +14.8% | 0.00% | – |
Q1 2020 | $29,000 | -31.0% | 8,366 | 0.0% | 0.00% | – |
Q4 2019 | $42,000 | +23.5% | 8,366 | -46.9% | 0.00% | – |
Q2 2019 | $34,000 | -19.0% | 15,767 | 0.0% | 0.00% | – |
Q1 2019 | $42,000 | -42.5% | 15,767 | 0.0% | 0.00% | – |
Q4 2018 | $73,000 | -51.0% | 15,767 | 0.0% | 0.00% | – |
Q3 2018 | $149,000 | -2.6% | 15,767 | 0.0% | 0.00% | – |
Q2 2018 | $153,000 | +61.1% | 15,767 | +75.1% | 0.00% | – |
Q1 2018 | $95,000 | +63.8% | 9,004 | 0.0% | 0.00% | – |
Q4 2017 | $58,000 | -13.4% | 9,004 | 0.0% | 0.00% | – |
Q3 2017 | $67,000 | +4.7% | 9,004 | 0.0% | 0.00% | – |
Q2 2017 | $64,000 | +82.9% | 9,004 | 0.0% | 0.00% | – |
Q1 2017 | $35,000 | +94.4% | 9,004 | 0.0% | 0.00% | – |
Q4 2016 | $18,000 | -62.5% | 9,004 | -50.0% | 0.00% | – |
Q3 2016 | $48,000 | +71.4% | 18,008 | +100.0% | 0.00% | – |
Q2 2016 | $28,000 | -63.6% | 9,004 | 0.0% | 0.00% | – |
Q1 2016 | $77,000 | -36.9% | 9,004 | 0.0% | 0.00% | – |
Q4 2015 | $122,000 | +40.2% | 9,004 | 0.0% | 0.00% | – |
Q3 2015 | $87,000 | -33.6% | 9,004 | -1.5% | 0.00% | – |
Q2 2015 | $131,000 | +336.7% | 9,145 | +168.0% | 0.00% | – |
Q1 2015 | $30,000 | +50.0% | 3,412 | +4.3% | 0.00% | – |
Q4 2014 | $20,000 | -47.4% | 3,271 | -6.9% | 0.00% | – |
Q3 2014 | $38,000 | -9.5% | 3,515 | 0.0% | 0.00% | – |
Q2 2014 | $42,000 | -19.2% | 3,515 | 0.0% | 0.00% | – |
Q1 2014 | $52,000 | +8.3% | 3,515 | +7.5% | 0.00% | – |
Q4 2013 | $48,000 | – | 3,271 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SILVERARC CAPITAL MANAGEMENT, LLC | 600,000 | $3,870,000 | 2.25% |
CM Management, LLC | 375,000 | $2,419,000 | 2.24% |
Consonance Capital Management LP | 3,515,944 | $22,678,000 | 2.12% |
RA Capital Management | 18,417,458 | $118,793,000 | 1.66% |
Kercheville Advisors, LLC | 244,421 | $1,564,000 | 0.85% |
Redmile Group, LLC | 10,528,179 | $67,907,000 | 0.82% |
Birchview Capital, LP | 190,000 | $1,226,000 | 0.71% |
QVT Financial LP | 1,375,900 | $8,875,000 | 0.49% |
Fernwood Investment Management, LLC | 149,340 | $963,000 | 0.38% |
TWIN FOCUS CAPITAL PARTNERS, LLC | 104,068 | $671,000 | 0.21% |